PCI 3.06.26

Current Edition

Current Features

Subsection - Neurodegenerative Diseases

From Depression to Deep-Learning: Leveraging iPSC and AI Platforms for Evidence-Based Depression Treatment

Continue reading

Subsection - Oncology

Essential DMPK Strategies for IND Success

Continue reading

Subsection - Cell and Gene Therapy

When the Gene Editing Guide is the Drug

Continue reading

Upcoming Events

CPHI 2027
AI in Drug Discovery
DDL 2026
Biotechnology Show 13.02.26

Advertisement

Advertisement

A&M Stabtest April 26

Advertisement

Biopharma Group – 19th March 2025

Advertisement

Micron View

Advertisement

Bachem skyscraper

Advertisement

Fujifilm
Volume 9 Issue 1

Vertical Integration: Building Resilience and Scalability in Nucleic Acid Therapeutics Manufacturing

The Shift Towards an Integrated Supply ModelThe biopharmaceutical sector is entering a new phase shaped by the clinical and commercial momentumof nucleic acid th...
Continue Reading →
Volume 9 Issue 1

Mitigating At-Risk Cell and Gene Therapy Application with Rapid Sterility Testing

Modern medicine is predicated on the safety provided by sterility assurance and aseptic practices. The United States Pharmacopeia defines these two important con...
Continue Reading →
Volume 9 Issue 1

From Policy to Practice: How Regulatory Momentum for New Approach Methodologies Is Accelerating the Adoption of Organ-on-a-Chip Technology

A Turning Point for Drug Development Models The biopharmaceutical industry is at an inflexion point. For decades, animal models have served as the backbone of...
Continue Reading →
Volume 9 Issue 1

Bridging the ADMET Translational Gap: How New Approach Methodologies and Organ-on-a-Chip Technology Are Redefining Drug Development

Drug developers face challenges in translating preclinical findings to safe and effective human trials. Traditionally,preclinical testing relies on a phased appr...
Continue Reading →
Volume 9 Issue 1

The CRISPR Revolution: Redefining Therapeutic Strategy and Pharmaceutical Innovation

For decades, medicine has focused primarily on disease management. Patients with genetic disorders often required lifelong therapy, controlling symptoms but rare...
Continue Reading →
Volume 8 Issue 4

The Analytical Landscape in mRNA Therapeutics: Characterisation and Batch Release Strategies

Messenger-RNA (mRNA) drug therapeutics have recently emerged as promising and increasingly viable treatment modalities for cancer, cardiovascular diseases, rare gene...
Continue Reading →
Volume 8 Issue 4

Overlap and Differences Between Bacterial Endotoxin Testing and Extractables and Leachables Testing

In the world of pharmaceutical and medical device manufacturing, there are various quality control tests that may be required for distinct product types from separat...
Continue Reading →
Volume 8 Issue 4

The Next Generation of Pharmacological Treatments for Chronic Disease

The success of GLP-1 receptor agonists as obesity therapeutics has initiated a seismic shift in the treatment paradigm and conceptual understanding of non-communicab...
Continue Reading →
Volume 8 Issue 4

Optimising Clinical Trials Through Integrated Biomarker and Translational Data Models

Clinical trials bridge the gap between discovery and patient care, but high failure rates, unpredictable patient responses and data variability continue to challenge...
Continue Reading →
Volume 8 Issue 4

Overcoming the Challenges of Developing Cell and Gene Therapies for Autoimmune Disorders

Autoimmune diseases such as lupus, type 1 diabetes, inflammatory bowel disease (Crohn’s disease or ulcerative colitis) and rheumatoid arthritis are complex condition...
Continue Reading →

Advertisement

Richter: Wed 23 October 2024, 09:03

Advertisement

Aseptic Tech

Advertisement

Steribar – 12.05.2025

Advertisement

PharmExcel

Advertisement

Polypure hompage

Advertisement

Gen Xpro

Advertisement

Alphinity

Advertisement

Crown Bioscience

Advertisement

Shimadzu

Advertisement

CPC